Orland Properties Ltd
Long book
$266.8M
Q1 2026
Positions
10
Top-10 weight
100%
concentration
Last quarter
+0.1%
SPY +14.8%
Turnover
10%
of book per quarter
Strategy in plain words
auto-generated from filingsOrland Properties Ltd is a concentrated fundamental stock-picker, specialised in financials (85% of the long book), running a $266.8M US long book across 10 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. The book barely moves quarter to quarter — a patient, low-turnover holder. Current anchor positions: FIGURE TECHNOLOGY SOLUT-CL A, CHIME FINANCIAL INC-CL A, LYELL IMMUNOPHARMA INC, XPENG INC - ADR, PDD HOLDINGS INC.
Over the last 9 quarters its long book ran on average 4.4pp per quarter behind the S&P 500, beating the index in 3 of 9 quarters. We rate its filings highest-signal: new buys here are worth attention.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
-7.5%
Q2 2024
+17.2%
Q3 2024
-1.6%
Q4 2024
+20.7%
Q1 2025
-4.1%
Q2 2025
-18.5%
Q3 2025
+14.3%
Q4 2025
-19.9%
Q1 2026
+0.1%
Sector allocation
Financials 93%
Healthcare 6%
Technology 0%
Long book by quarter
What does Orland Properties own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| FIGR FIGURE TECHNOLOGY SOLUT-CL A | Financials | 4.0M | $134.4M | 50.4% | -54.9% |
| CHYM CHIME FINANCIAL INC-CL A | Financials | 4.6M | $86.3M | 32.4% | Held |
| LYEL LYELL IMMUNOPHARMA INC | Healthcare | 754.7K | $15.1M | 5.7% | Held |
| YMT YIMUTIAN INC | Technology | 2.5M | $427K | 0.2% | Held |
| VIA VIA TRANSPORTATION INC-CL A | Technology | 15.2K | $228K | 0.1% | Held |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 6, 2026 | 10 | $266.8M | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 17, 2026 | 9 | $534.4M | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 12, 2025 | 9 | $467.6M | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 14, 2025 | 8 | $236.1M | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 13, 2025 | 7 | $82.9M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 14, 2025 | 7 | $68.6M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 8, 2024 | 11 | $149.3M | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 13, 2024 | 12 | $131.6M | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 14, 2024 | 12 | $176.9M | canonical | SEC ↗ |